Online Appendices
- Appendix 1: Checklist of recommendations for reporting of observational studies using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines
- Appendix 10: Event rates for 14-day hospital encounter with ventricular arrhythmia and all-cause mortality in matched cohort of patients prescribed macrolide antibiotics compared to referent non-macrolide antibiotics
- Appendix 11: Summary of nine published studies describing cardiovascular events and mortality associated with macrolide use compared with other classes of antibiotics or non-use for the treatment of respiratory tract infections
- Appendix 12: Modified Downs and Black checklist for the assessment of the methodological quality of both randomized and non-randomized studies
- Appendix 2: Coding definitions for demographic and comorbid conditions
- Appendix 3: Coding definitions for hospital encounter with ventricular arrhythmia and all-cause mortality
- Appendix 4: Standard daily drug doses for the treatment of respiratory tract infections
- Appendix 5: Variables included in the propensity score
- Appendix 6: QT-prolonging drugs included in subgroup analysis
- Appendix 7: Flow diagram of cohort selection
- Appendix 8: Baseline characteristics of macrolide antibiotic users and non-macrolide antibiotic users pre- and post-match
- Appendix 9: 30-day hospital admission encounter with ventricular arrhythmia and all-cause mortality in unmatched cohort of patients prescribed macrolide antibiotics compared to referent non-macrolide antibiotics